128 related articles for article (PubMed ID: 2792720)
1. [Clinical picture and diagnosis of refractory anemia with an excess of blasts and with bone marrow hypoplasia].
Gladysh VV; Turbina NS; Mikhaĭlova EA; Ustinova EN; Pylaeva NN
Gematol Transfuziol; 1989 Jul; 34(7):6-10. PubMed ID: 2792720
[TBL] [Abstract][Full Text] [Related]
2. Refractory anaemia with excess blasts (RAEB) in a child--an unusual clinicohaematological presentation--a case report.
Narayan S; Sharma S; Chandra J; Gautam S; Banga V
Indian J Pathol Microbiol; 2001 Jul; 44(3):369-70. PubMed ID: 12024939
[TBL] [Abstract][Full Text] [Related]
3. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
4. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
5. [Emperipolesis by megakaryocytes in RAEB in T (refractory anemia with excess of blasts in transformation)].
Natori H; Natori K; Naito K; Nakamura E; Tanaka K; Egami K; Honda J; Imamura Y; Osabe S; Yasuda K
Rinsho Ketsueki; 1988 Sep; 29(9):1504-10. PubMed ID: 3216522
[No Abstract] [Full Text] [Related]
6. Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.
Michels SD; Saumur J; Arthur DC; Robison LL; Brunning RD
Cancer; 1989 Dec; 64(11):2340-6. PubMed ID: 2804925
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
9. [Refractory anemia with excess of blasts (RAEB) and erythroleukemia (M6) in two brothers].
Takahira H; Ogo J; Nishimura J; Ibayashi H; Umemura T; Hirata J; Toyomura M; Asayama R
Rinsho Ketsueki; 1988 Mar; 29(3):395-401. PubMed ID: 3165146
[No Abstract] [Full Text] [Related]
10. CD 34 immunotyping of blasts in myelodysplasia.
Oertel J; Oertel B; Beyer J; Huhn D
Ann Hematol; 1994 Feb; 68(2):77-80. PubMed ID: 7511934
[TBL] [Abstract][Full Text] [Related]
11. RAEB-t in young adults--a rare entity.
Tilak V; Akhtar S; Alam K
Indian J Pathol Microbiol; 2003 Apr; 46(2):228-30. PubMed ID: 15022920
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects and diagnosis of refractory anemia with excess of blasts].
Gladysh VV; Turbina NS
Klin Med (Mosk); 1990 Nov; 68(11):84-7. PubMed ID: 2283827
[No Abstract] [Full Text] [Related]
14. [Serum proteomics in patients with RAEB myelodysplastic syndromes].
Zhong LY; Liu TH; Li YQ; Geng SX; Lu ZS; Weng JY; Wu SJ; Luo CW; Du X
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1799-801. PubMed ID: 19778794
[TBL] [Abstract][Full Text] [Related]
15. [Clarification of possible anemia].
Uprichard J; Bain BJ
Praxis (Bern 1994); 2009 Dec; 98(24):1453-5. PubMed ID: 19953471
[No Abstract] [Full Text] [Related]
16. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the PD-1 Pathway in Myelodysplastic Syndrome.
Mukherjee S; Ibrahimi S; Aljumaily R; Cherry M
Am J Ther; 2018; 25(6):e711-e712. PubMed ID: 29394170
[No Abstract] [Full Text] [Related]
18. Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses.
Iwabuchi A; Ohyashiki K; Ohyashiki JH; Kimura Y; Lin KY; Aizawa S; Nehashi Y; Miyazawa K; Yaguchi M; Toyama K
Int J Hematol; 1994 Oct; 60(3):207-13. PubMed ID: 7858240
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis, course and outcome of myelodysplasias].
Riauzova LIu; Soloveĭ DIa; Iavorkovskiĭ LI; Iavorkovskiĭ LL; Grinberg LIa
Gematol Transfuziol; 1988 Aug; 33(8):19-23. PubMed ID: 3192050
[No Abstract] [Full Text] [Related]
20. Coexistence of myelodysplastic syndrome and multiple myeloma.
Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
